Developing a Sound Process Validation Strategy - - BioPharm International

ADVERTISEMENT

Developing a Sound Process Validation Strategy


BioPharm International
Volume 20, Issue 12

5. Shadle PJ. Qualification of raw materials for biopharmaceutical use. BioPharm Int. 2004; 2:28–41.

6. Ritter N, et al. What is test method qualification? Proceedings of the WCBP Strategy Forum. 2003 Jul 24. Gaithersburg, MD.

7. ICH. Q2(R1), Validation of analytical procedures: text and methodology. Geneva, Switzerland; 2005.

8. Brunkow R, et al. Cleaning and cleaning validation: a biotechnology perspective. Bethesda, MD: Parenteral Drug Association; 1995.

9. Hall W. Validation and verification of cleaning processes. In: Nash R, Wachter A. editors. Pharmaceutical process validation. New York: Informa Health Care; 2003. p. 465–506.

10. The Automotive Division of the American Society for Quality (ASQC) and the Automotive Industry Action Group (AIAG). Potential failure mode and effects analysis, FMEA. 1995 Feb. Southfield, MI: AIAG.

11. Montgomery DC. Design and Analysis of Experiments, 4th ed. New York: John Wiley & Sons, Inc.; 1997.

12. Parenteral Drug Association. PDA technical report no. 42: Process validation of protein manufacturing. Bethesda, MD: PDA; 2005.

13. US Food and Drug Administration. Guidance for industry. Guidelines on general principles of process validation. Rockville, MD; 1987.

14. Ferenc BM. Qualification and change control in validation of pharmaceutical processes, 2nd ed.; Carleton F, Agalloco J. editors. New York: Marcell Dekker, Inc.; 1999; p. 132–150.

15. The Automotive Division of the American Society for Quality (ASQC) and the Automotive Industry Action Group (AIAG). Statistical process control (SPC) reference manual; 1995 Mar. Southfield, MI: AIAG.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here